APA (7th ed.) Citation

SK, G., C, D., T, U., S, M., RH, C., SM, C., . . . HJ, R. (2026). Inflammatory, Cardiac, and Lipid-Related Biomarkers in Relation to Residual MACE Risk in the REPRIEVE Trial. JACC. Advances, 5(8), 102984. https://doi.org/10.1016/j.jacadv.2026.102984

Chicago Style (17th ed.) Citation

SK, Grinspoon, et al. "Inflammatory, Cardiac, and Lipid-Related Biomarkers in Relation to Residual MACE Risk in the REPRIEVE Trial." JACC. Advances 5, no. 8 (2026): 102984. https://doi.org/10.1016/j.jacadv.2026.102984.

MLA (9th ed.) Citation

SK, Grinspoon, et al. "Inflammatory, Cardiac, and Lipid-Related Biomarkers in Relation to Residual MACE Risk in the REPRIEVE Trial." JACC. Advances, vol. 5, no. 8, 2026, p. 102984, https://doi.org/10.1016/j.jacadv.2026.102984.